See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2023_IONIS_PHARMACEUTICALS_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.4690038187305396, 'aggregate_val': 1960989000, 'exp_sum': 794243000, 'exp_to_value': {'LiabilitiesCurrent': 311561000, 'LiabilitiesNoncurrent': 473835000, 'remainder_Liabilities': 8847000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000874015, IONIS PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,202,694,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 74,294,000 |
| 3 | remainder_Assets | 256,888,000 |
| 4 | LiabilitiesCurrent | 311,561,000 |
| 5 | LiabilitiesNoncurrent | 473,835,000 |
| 6 | remainder_Liabilities | 1,175,593,000 |
| 7 | CostOfGoodsAndServicesSold | 14,116,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 150,295,000 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 853,006,000 |
| 11 | remainder_Revenues | 587,367,000 |
| 12 | remainder_NetIncome | 160,328,000 |
| 13 | remainder_ComprehensiveNetIncome | -24,812,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,533,876,000 |
| 1 | Liabilities | 1,960,989,000 |
| 2 | Expenses | 1,017,417,000 |
| 3 | Revenues | 587,367,000 |
| 4 | StockholdersEquity | 572,887,000 |
| 5 | NetIncome | -269,722,000 |
| 6 | ComprehensiveNetIncome | -282,128,000 |
| 7 | BaseVar | 3,142,394,500 |
| 8 | EconomicCapitalRatio | 0.313 |
Edgar->Model Mapping
Feature Distribution
Change over Time
